Bristol Myers Squibb Co. (BMY)
61.50
+0.35
(+0.57%)
USD |
NYSE |
Sep 24, 16:00
61.55
+0.05
(+0.08%)
After-Hours: 19:59
Bristol Myers Squibb Gross Profit (Annual) : 31.76B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 31.76B |
| December 31, 2024 | 27.43B |
| December 31, 2023 | 25.36B |
| December 31, 2022 | 26.49B |
| December 31, 2021 | 26.76B |
| December 31, 2020 | 21.70B |
| December 31, 2019 | 17.25B |
| December 31, 2018 | 16.08B |
| December 31, 2017 | 14.96B |
| December 31, 2016 | 14.50B |
| December 31, 2015 | 12.81B |
| December 31, 2014 | 12.00B |
| December 31, 2013 | 11.80B |
| December 31, 2012 | 13.19B |
| December 31, 2011 | 15.72B |
| December 31, 2010 | 14.33B |
| December 31, 2009 | 13.78B |
| December 31, 2008 | 14.44B |
| December 31, 2007 | 13.21B |
| December 31, 2006 | 11.68B |
| December 31, 2005 | 13.38B |
| December 31, 2004 | 13.57B |
| December 31, 2003 | 13.31B |
| Date | Value |
|---|---|
| December 31, 2002 | 11.59B |
| December 31, 2001 | 12.53B |
| December 31, 2000 | 13.46B |
| December 31, 1999 | 14.68B |
| December 31, 1998 | 13.43B |
| December 31, 1997 | 12.24B |
| December 31, 1996 | 11.10B |
| December 31, 1995 | 10.13B |
| December 31, 1994 | 8.862B |
| December 31, 1993 | 8.384B |
| December 31, 1992 | 8.299B |
| December 31, 1991 | 8.229B |
| December 31, 1990 | 7.426B |
| December 31, 1989 | 6.533B |
| December 31, 1988 | 4.169B |
| December 31, 1987 | 3.722B |
| December 31, 1986 | 3.321B |
| December 31, 1985 | 2.976B |
| December 31, 1984 | 2.780B |
| December 31, 1983 | 2.531B |
| December 31, 1982 | 2.301B |
| December 31, 1981 | 2.169B |
| December 31, 1980 | 1.962B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Johnson & Johnson | 64.63B |
| Eli Lilly & Co. | 54.13B |
| Merck & Co., Inc. | 46.73B |
| Pfizer Inc. | 41.04B |
| AstraZeneca PLC | 43.95B |